National Action Plan For The MHPSS Response To COVID-19

National Action Plan for the MHPSS Response to COVID-19

This action plan was developed as part of the national response to the COVID-19 outbreak. It aims at comprehensively addressing the MHPSS aspects of the COVID-19 outbreak in Lebanon for all persons living in the country. It was developed by the MOPH-National Mental Health Programme (NMHP) with WHO and UNICEF, in line with the IASC Briefing note on addressing mental health and psychosocial aspects of COVID-19 Outbreak- version 1.0 and the local needs, health system and national mental health strategy.

Goals:

Promote mental health and mitigate COVID-19 related stressors including stigma and discrimination against persons affected and health workers.
Provide mental health support to the persons in quarantine in the hospital or at home and their families.
Support the mental health of health workers and first responders in the response.
Ensure continuity of mental health care for persons using mental health services in line with IPC guidelines.

To view the action plan, click here: National Action Plan for MHPSS Response to COVID-19

All

ATC	Name	B/G	Ingredients ↓	Dosage	Form	Price
N02CC03	ZOLMITRIPTAN ARROW GENERIGUES	G	Zolmitriptan - 2.5mg	2.5mg	Tablet, film coated	1,726,838 L.L
N02CC03	ZOLMITRIPTAN ARROW GENERIGUES	G	Zolmitriptan - 2.5mg	2.5mg	Tablet, film coated	857,372 L.L
N02CC03	ZOLMITRIPTAN BIOGARAN	G	Zolmitriptan - 2.5mg	2.5mg	Tablet, orodispersible	921,876 L.L
N02CC03	ZOLMITRIPTAN BIOGARAN	G	Zolmitriptan - 2.5mg	2.5mg	Tablet, orodispersible	1,683,835 L.L
M05BA08	ZOLEDRO-DENK	G	Zoledronic acid - 4mg/5ml	4mg/5ml	Injectable concentrate for solution	4,388,990 L.L
M05BA08	ZOLEDRONIC ACID ACCORD	G	Zoledronic acid - 4mg/5ml	4mg/5ml	Injectable concentrate for solution	7,028,741 L.L
M05BA08	ZOLEDRO-DENK	G	Zoledronic acid - 4mg/5ml	4mg/5ml	Injectable concentrate for solution	L.L
M05BA08	ZOLEDRA	G	Zoledronic acid - 4mg	4mg	Injectable powder for solution	6,368,470 L.L
M05BA08	ZOLEDRONIC ACID HIKMA	G	Zoledronic acid (monohydrate) - 4mg/5ml	4mg/5ml	Injectable concentrate for solution	9,098,466 L.L
L01EC01	ZELBORAF	B	Vemurafenib - 240mg	240mg	Tablet, film coated	L.L
L01EC01	ZELBORAF	B	Vemurafenib - 240mg	240mg	Tablet, film coated	142,041,587 L.L
J01XA01	ZERMACIN	G	Vancomycin (HCl) - 1g	1g	Injectable lyophilised powder for solution	1,066,115 L.L
J01XA01	ZERMACIN	G	Vancomycin (HCl) - 1g	1g	Injectable lyophilised powder for solution	6,911,190 L.L
J01XA01	ZERMACIN	G	Vancomycin (HCl) - 0.5g	0.5g	Injectable sterile lyophilised powder for solution	840,861 L.L
J01XA01	ZERMACIN	G	Vancomycin (HCl) - 0.5g	0.5g	Injectable sterile lyophilised powder for solution	5,875,791 L.L
A10BD07	ZERILUX	G	Sitagliptin - 25mg/ml	25mg/ml	Solution	1,172,179 L.L
C10AA01	ZOCOR	B	Simvastatin - 40mg	40mg	Tablet	1,435,992 L.L
C10AA01	ZOCOR	B	Simvastatin - 20mg	20mg	Tablet	976,526 L.L
C10AA01	ZOCOR	B	Simvastatin - 10mg	10mg	Tablet	881,817 L.L
N06AB06	ZOLOFT	B	Sertraline HCl - 50mg	50mg	Tablet, scored	596,666 L.L
N06AB06	ZOLOFT	B	Sertraline HCl - 50mg	50mg	Tablet, scored	596,666 L.L
R03AK12	ZEPHIRUS	B	Salmeterol - 20mcg, Budesonide - 240mcg		Capsule, inhalation	1,678,459 L.L
R03AK12	ZEPHIRUS	B	Salmeterol - 20mcg, Budesonide - 120mcg		Capsule, inhalation	1,412,378 L.L
C10BA06	ZYMPASS	B	Rosuvastatin (calcium) - 40mg, Ezetimibe - 10mg		Tablet, film coated	2,482,077 L.L
C10BA06	ZYMPASS	B	Rosuvastatin (calcium) - 20mg, Ezetimibe - 10mg		Tablet, film coated	2,482,077 L.L
C10BA06	ZYMPASS	B	Rosuvastatin (calcium) - 10mg, Ezetimibe - 10mg		Tablet, film coated	2,138,053 L.L
B01AF01	ZARLAN	G	Rivaroxaban - 20mg	20mg	Tablet, film coated	1,343,843 L.L
B01AF01	ZARLAN	G	Rivaroxaban - 15mg	15mg	Tablet, film coated	2,015,764 L.L
B01AF01	ZARLAN	G	Rivaroxaban - 15mg	15mg	Tablet, film coated	1,343,843 L.L
B01AF01	ZARLAN	G	Rivaroxaban - 10mg	10mg	Tablet, film coated	1,439,255 L.L